Recombinant Human CEACAM-5/CD66e Fc Chimera Protein, CF
R&D Systems, part of Bio-Techne | Catalog # 10449-CM
HEK293 Expressed Protein
Key Product Details
Source
HEK293
Accession #
Structure / Form
Disulfide-linked homodimer
Conjugate
Unconjugated
Applications
Bioactivity
Product Specifications
Source
Human embryonic kidney cell, HEK293-derived human CEACAM-5/CD66e protein
Human CEACAM-5/CD66e (Lys35-Ala685) Accession # NP_004354.3 |
IEGRMD | Human IgG1 (Pro100-Lys330) |
N-terminus | C-terminus |
Purity
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Level
<0.10 EU per 1 μg of the protein by the LAL method.
N-terminal Sequence Analysis
Lys35
Predicted Molecular Mass
96 kDa
SDS-PAGE
135-175 kDa, under reducing conditions.
Activity
Measured by its binding ability in a functional ELISA.
When Recombinant Human CEACAM-5/CD66e Fc Chimera (Catalog # 10449-CM) is immobilized at 0.5 µg/mL (100 µL/well), Recombinant Human Galectin-4 (Catalog # 1227-GA) binds with an ED50 of 10-90 ng/mL.
When Recombinant Human CEACAM-5/CD66e Fc Chimera (Catalog # 10449-CM) is immobilized at 0.5 µg/mL (100 µL/well), Recombinant Human Galectin-4 (Catalog # 1227-GA) binds with an ED50 of 10-90 ng/mL.
Scientific Data Images for Recombinant Human CEACAM-5/CD66e Fc Chimera Protein, CF
Recombinant Human CEACAM-5/CD66e Fc Chimera Protein SDS-PAGE
2 μg/lane of Recombinant Human CEACAM-5/CD66e Fc Chimera Protein (Catalog # 10449-CM) was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie® Blue staining, showing bands at 135-175 kDa and 270-330 kDa, respectively.Formulation, Preparation and Storage
10449-CM
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution | Reconstitute at 400 μg/mL in PBS. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: CEACAM-5/CD66e
References
- Zebhauser, R. et al. (2005) Genomics 86:566.
- Hammarstrom, S. (1999) Semin. Cancer Biol. 9:67.
- Chan, et al. (2007) Curr Oncol. 14:70.
- Schrewe, H. et al. (1990) Mol. Cell. Biol. 10:2738.
- Hefta, S.A. et al. (1988) Proc. Natl. Acad. Sci. 85:4648.
- Hance, K.W. et al. Mutat Res. (2005) 576:132.
- Stern, N. et al. (2005) J. Immunol. 174:6692.
- Beauchemin N. et al. (2013) Cancer Metastasis Rev. 32:3.
- Blumenthal, R.D. et al. (2005) Cancer Res. 65:8809.
- Screaton, R.A. et al. (1997) J. Cell Biol. 137:939.
- Ordonez, C. et al. (2000) Cancer Res. 60:3419.
- Yamamoto, Y. et al. (2005) Biochem. Biophys. Res. Commun. 333:223.
- Ideo, H. et al. (2005) J Biol Chem. 280:4730.
- Martin, J.N. et al. (2016) Biochemistry. 55:4286.
- Berger, C.N. et al. (2004) Mol. Microbiol. 52:963.
- Tchoupa, A.K. et al. (2014) Cell Commun Signal. 12:27.
Long Name
Carcinoembryonic Antigen-related Cell Adhesion Molecule 5
Alternate Names
CD66e, CEA, CEACAM5
Gene Symbol
CEACAM5
UniProt
Additional CEACAM-5/CD66e Products
Product Documents for Recombinant Human CEACAM-5/CD66e Fc Chimera Protein, CF
Product Specific Notices for Recombinant Human CEACAM-5/CD66e Fc Chimera Protein, CF
For research use only
Loading...
Loading...
Loading...
Loading...